BlueRock Therapeutics Stock

bluerocktx.comHealthcareFounded: 2016Funding to Date: $225MM

BlueRock Therapeutics is an engineered cell therapy company with a mission to develop regenerative medicines for intractable diseases with a platform that harnesses the power of cells for new medicines across neurology, cardiology and autoimmune indications.

Register for Details

For more details on financing and valuation for BlueRock Therapeutics, register or login.

Please provide a valid email address.

By registering, you agree to Forge’s Terms of Use. Already registered? Log in

Enterprise Value (based on primary financings)

Powered by Forge Data
Enterprise Value

View Enterprise Value for BlueRock Therapeutics.

Register Today


Management Team

Emile Nuwaysir Ph.D
Chief Executive Officer, President & Board Member
Gordon Keller Ph.D
Scientific Co-Founder
Shane Kovacs
Chief Business and Financial Officer
Min Wang Ph.D
Chief Administrative & Legal Officer
Lorenz Studer Ph.D
Scientific Co-Founder
Robert Deans Ph.D
Chief Technology Officer
Joachim Fruebis Ph.D
Chief Development Officer
Michael Scott Ph.D
Senior Vice President, Product Development

Board Members

Bradley Bolzon Ph.D
Versant Venture Management
Jerel Davis Ph.D
Versant Venture Management
Jurg Eckardt MD
Axel Bouchon

Other companies like BlueRock Therapeutics in the Healthcare sector

Last Round Est. Valuation
Last Round Est. Valuation
Last Round Est. Valuation
Last Round Est. Valuation
Last Round Est. Valuation